Research / DT / Fundamental state Inspectable configuration
State dimensions Filing 0001773383-22-000053 General Corporate
Debt relative to revenue 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
29.47% · OPTIONAL · VALID
Capex intensity 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.90% · OPTIONAL · VALID
Operating cash generation 64th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
27.00% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
32.12% · CORE · NOT_ENOUGH_HISTORY
Gross margin 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
81.40% · CORE · VALID
Operating margin 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
8.75% · CORE · VALID
R&D intensity 64th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.82% · OPTIONAL · VALID
SBC intensity 55th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.71% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 7/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 126.02%
Current 29.47%
Delta -96.55% Capex Intensity Increased
Previous 1.73%
Current 1.90%
Delta 0.18% Cash Generation Increased
Previous 25.27%
Current 27.00%
Delta 1.73% Growth Increased
Previous 31.63%
Current 32.12%
Delta 0.49% Margin Decreased
Previous 81.53%
Current 81.40%
Delta -0.13% Profitability Decreased
Previous 8.81%
Current 8.75%
Delta -0.06% R And D Intensity Decreased
Previous 16.98%
Current 16.82%
Delta -0.16% Sbc Intensity Decreased
Previous 11.27%
Current 10.71%
Delta -0.56% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.